Graduate Student

I am a third year graduate student in the BCMB program at Weill Cornell Graduate School. I received my B.S. from Binghamton University where I studied microbiological cycling of toxic trace metalloids in the Kulp lab. Post-graduation I joined the Kirkman Lab as a research technician, focusing on anti-malarial compound development and drug resistance in Babesia microti. I returned to the research group to attain my PhD in the Deitsch lab. I am interested in understanding the factors that influence translational control in P. falciparum.

When I am not in the lab I spend my free time outdoors as much as possible. I enjoy running, biking, and hiking.  I try to get out to the mountains a few times a year for snowboarding.

Publications:

Improvement of Asparagine Ethylenediamines as Anti-malarial Plasmodium-Selective Proteasome Inhibitors .Zhan W, Visone J, Ouellette T, Harris JC, Wang R, Zhang H, Singh PK, Ginn J, Sukenick G, Wong TT, Okoro JI, Scales RM, Tumwebaze PK, Rosenthal PJ, Kafsack BFC, Cooper RA, Meinke PT, Kirkman LA, Lin G. J Med Chem. 2019 Jul 11;62(13):6137-6145.

Antimalarial proteasome inhibitor reveals collateral sensitivity from intersubunit interactions and fitness cost of resistance. Kirkman LA, Zhan W, Visone J, Dziedziech A, Singh PK, Fan H, Tong X, Bruzual I, Hara R, Kawasaki M, Imaeda T, Okamoto R, Sato K, Michino M, Alvaro EF, Guiang LF, Sanz L, Mota DJ, Govindasamy K, Wang R, Ling Y, Tumwebaze PK, Sukenick G, Shi L, Vendome J, Bhanot P, Rosenthal PJ, Aso K, Foley MA, Cooper RA, Kafsack B, Doggett JS, Nathan CF, Lin G. Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6863-E6870.

Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia. Simon MS, Westblade LF, Dziedziech A, Visone JE, Furman RR, Jenkins SG, Schuetz AN, Kirkman LA. Clin Infect Dis. 2017 Oct 1;65(7):1222-1225.